BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10071341)

  • 1. Hodgkin's disease: classification and differential diagnosis.
    Harris NL
    Mod Pathol; 1999 Feb; 12(2):159-75. PubMed ID: 10071341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin's lymphomas: classification, diagnosis, and grading.
    Harris NL
    Semin Hematol; 1999 Jul; 36(3):220-32. PubMed ID: 10462322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The many faces of Hodgkin's disease around the world: what have we learned from its pathology?
    Harris NL
    Ann Oncol; 1998; 9 Suppl 5():S45-56. PubMed ID: 9926237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: immunophenotypic and molecular studies.
    Chan WC
    Semin Hematol; 1999 Jul; 36(3):242-52. PubMed ID: 10462324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology of Hodgkin's lymphoma.
    Eberle FC; Mani H; Jaffe ES
    Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hodgkin's disease--an entity?].
    Hansmann ML
    Verh Dtsch Ges Pathol; 1992; 76():24-36. PubMed ID: 1283267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
    Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
    Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodular lymphocyte predominant Hodgkin's disease and anaplastic large-cell (CD30+) lymphoma: distinct entities or nonspecific patterns?
    Menestrina F; Chilosi M; Scarpa A
    Semin Diagn Pathol; 1995 Aug; 12(3):256-69. PubMed ID: 8545592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
    Fong D; Kaiser A; Spizzo G; Gastl G; Tzankov A
    Br J Haematol; 2005 Apr; 129(2):199-205. PubMed ID: 15813847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
    Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
    Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune reactions in classical Hodgkin's lymphoma.
    Poppema S; Potters M; Emmens R; Visser L; van den Berg A
    Semin Hematol; 1999 Jul; 36(3):253-9. PubMed ID: 10462325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
    Peh SC; Kim LH; Poppema S
    Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large B-cell lymphoma with Hodgkin's features.
    García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
    Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distinction of Hodgkin's disease from T cell lymphoma.
    Banks PM
    Semin Diagn Pathol; 1992 Nov; 9(4):279-83. PubMed ID: 1480849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-associated Hodgkin's lymphoma.
    Gandhi MK; Tellam JT; Khanna R
    Br J Haematol; 2004 May; 125(3):267-81. PubMed ID: 15086409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia.
    Hudnall SD; Betancourt E; Barnhart E; Patel J
    Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of malignant lymphomas in Klang Hospital, a public hospital in Malaysia.
    Peh SC; Kim LH; Thanaletchimy N; Chai SP; Poppema S
    Malays J Pathol; 2000 Jun; 22(1):13-20. PubMed ID: 16329532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.